Reply: Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia

被引：0
|
作者：
Daniel E Casey
David G Daniel
Adel A Wassef
Katherine A Tracy
Patricia Wozniak
Kenneth W Sommerville
机构：
[1] Oregon Health & Science University,
[2] George Washington University,undefined
[3] Bioniche Development,undefined
[4] HCPC-University of Texas,undefined
[5] Abbott Laboratories,undefined
[6] University of Illinois,undefined
[7] Schwarz Biosciences,undefined
[8] Research Triangle Park,undefined
来源：
Neuropsychopharmacology | 2004年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：637 / 638
页数：1
相关论文
共 50 条
  • [31] Cognitive effects of risperidone and olanzapine in patients with schizophrenia or schizoaffective disorder
    Mahmoud, R
    Harvey, PD
    Meltzer, HY
    Green, MF
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 236 - 237
  • [32] Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia
    Kasper, S
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 (06) : 253 - 262
  • [33] Clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia
    Brousse, Georges
    Meary, Alexandre
    Blanc, Olivier
    Lancon, Christophe
    Llorca, Pierre Michel
    Leboyer, Marion
    PSYCHIATRY RESEARCH, 2010, 179 (01) : 12 - 18
  • [34] Cognitive effects of risperidone and olanzapine in patients with schizophrenia or schizoaffective disorder
    Harvey, P
    Meltzer, H
    Green, M
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 123S - 123S
  • [35] Risperidone versus olanzapine in the treatment of patients with schizophrenia or schizoaffective disorder
    Brecher, M
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 271 - 271
  • [36] Two year outcomes on risperidone and olanzapine in stable patients with schizophrenia
    Marder, Stephen R.
    Noordsy, Douglas L.
    Glynn, Shirley M.
    O'Keefe, Christopher
    Almeida, Margaret A.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S250 - S250
  • [37] Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
    Zhang, Hongyan
    Li, Huafang
    Shu, Liang
    Gu, Niufan
    Wang, Gang
    Weng, Yongzhen
    Xie, Shiping
    Zhang, Xinbao
    Li, Ting
    Ma, Cui
    Yu, Wei
    Parsons, Bruce
    Schou, Manjula
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 77 - 85
  • [38] A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone
    Hatta, Kotaro
    Otachi, Taro
    Sudo, Yasuhiko
    Kuga, Hironori
    Takebayashi, Hiroshi
    Hayashi, Hideaki
    Ishii, Ryusuke
    Kasuya, Masataka
    Hayakawa, Tatsuro
    Morikawa, Fumiyoshi
    Hata, Kazuya
    Nakamura, Mitsuru
    Usui, Chie
    Nakamura, Hiroyuki
    Hirata, Toyoaki
    Sawa, Yutaka
    PSYCHIATRY RESEARCH, 2012, 198 (02) : 194 - 201
  • [39] Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone
    Kim, KS
    Pae, CU
    Chae, JH
    Bahk, WM
    Jun, TY
    Kim, DJ
    Dickson, RA
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (05) : 408 - 413
  • [40] Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia
    Lee, C
    Wu, KH
    Habil, H
    Dyachkova, Y
    Lee, P
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2006, 40 (05): : 437 - 445
12345